青光眼局部降眼压药专家共识和一线药物的发展

眼科 ›› 2012, Vol. 21 ›› Issue (1): 11-13.

青光眼局部降眼压药专家共识和一线药物的发展

任泽钦

100044北京大学人民医院眼科（Email：renzeqin@163.com）

出版日期:2012-01-25 发布日期:2012-01-12

The advances of the expert consensus and the first-line medications of topical intraocular pressure-lowering agents in glaucoma treatment.

REN Ze-qin

Department of Ophthalmology, People Hospital Peking University, Beijing 100044, China. Email: renzeqin@163.com

Online:2012-01-25 Published:2012-01-12

摘要/Abstract

摘要： 青光眼局部降眼压药物有六大类，临床指南中关于药物治疗的建议有利于指导青光眼治疗时的合理用药，尤其是目标眼压的确立及一线药物的选择。总体趋势是前列腺素类药物（PGA）将作为原发性开角型青光眼局部降眼压一线药物。起始治疗后单药疗效不能达到目标眼压时可转换药物、增加药物、激光或手术治疗。转换药物的指征为起始治疗不能降低眼压或降低幅度不够，后者也可增加药物。PGA对前房角部分关闭者的降眼压需进一步评价。临床用药的选择路径应是一个从规范化到个体化的过程。（眼科，2012，21：11-13）

关键词: 青光眼/药物疗法, 专家共识, 一线药物

Abstract: There are six main classifications and thousands of all combination schemes of topical intraocular pressure-lowering agents currently available in management of glaucoma. The clinical guidelines have kept renewing in recent years aiming to guide the clinical doctors in their maximum reasonable medical therapy. In the present paper, the selection path of drug application and the expert consensus from 2011 World Glaucoma Congress are briefly introduced, with the target intraocular pressure and the first-line medications as a center. (Ophthalmol CHN, 2012, 21: 11-13)

Key words: glaucoma/medical therapy, expert consensus, first-line medication

任泽钦. 青光眼局部降眼压药专家共识和一线药物的发展[J]. 眼科, 2012, 21(1): 11-13.

REN Ze-qin. The advances of the expert consensus and the first-line medications of topical intraocular pressure-lowering agents in glaucoma treatment.[J]. Ophthalmology in China, 2012, 21(1): 11-13.

[1]	张恒丽唐广贤闫晓伟李凡马丽华耿玉磊. 曲伏前列素治疗抗青光眼术后眼压失控的原发性闭角型青光眼的短期疗效[J]. 眼科, 2016, 25(1): 36-39.
[2]	贺翔鸽. 新型抗青光眼药物——固定联合制剂[J]. 眼科, 2015, 24(6): 427-430.